Introduction
============

Blood loss during neurosurgery varies in magnitude from minimal to massive. Excessive blood loss is strongly associated with in-hospital morbidity and mortality. [@JR_1] Complications of transfusion translate into higher rates of sepsis, longer duration of hospital and intensive care unit (ICU) stay, and overall increased patient mortality. [@JR_2] [@JR_3] [@JR_4] [@JR_5] [@JR_6] [@JR_7] Several studies have identified complications associated with bleeding in patients with trauma, obstetric hemorrhage, cardiac surgery, liver transplantation, and oncological surgery. [@JR_8] [@JR_9] [@JR_10] [@JR_11] [@JR_12] [@JR_13] [@JR_14] However, studies addressing these complications during intracranial tumor surgery are not available. Hence, we planned this study to correlate the amount of intraoperative bleeding with perioperative complications and neurological outcome in patients undergoing brain tumor surgery.

Materials and Methods
=====================

After obtaining approval from the Institutional Ethics Committee and permission to access the patients' records, data of all adult patients between 18 and 60 years, who underwent elective surgery for brain tumor removal over a period of 1 year, were collected by reviewing the patients' medical records and intraoperative anesthesia charts.

Preoperative patient data, including age, sex, body weight, associated systemic illness, American Society of Anesthesiologists (ASA) physical status, type and site of lesion, the number of previous surgeries for the pathology, preoperative cardiorespiratory status, and preoperative baseline investigations, were collected. Estimated blood volume (EBV) of the individual patient was calculated on the basis of his or her gender (men: 70 mL/kg; women: 65 mL/kg).

Intraoperative anesthesia record and surgical notes were reviewed to collect data regarding type of anesthesia technique, surgical position, surgical procedure, hemodynamic stability, amount of blood loss, amount and type of intravenous (IV) fluid administered, amount of blood and blood components transfused, the use of vasopressors, the use of cell saver, and duration of surgery and anesthesia. Intraoperative complications such as hemodynamic instability, hypothermia, derangements in blood gases and acid-base status, dyselectrolytemia, arrhythmias, coagulation abnormality if any, and details of their management were noted. After completion of the surgery, it was also recorded whether the patient was extubated immediately or was mechanically ventilated.

Patients medical records were reviewed to note the development of postoperative complications within the first 48 hours related to blood loss and transfusion, such as anemia (hemoglobin \<8 g%), leukocytosis (total leukocyte count \>11,000/mm ^3^ ), thrombocytopenia (platelet count \<100,000/ mm ^3^ ), fever, coagulation abnormality, deranged hepatic/renal parameters, and further blood and component transfusion. Other complications such as neurological deficits, cardiovascular complications, pulmonary complications, infections (pulmonary, bloodstream, wound, meningitis, and sepsis), renal failure, electrolyte imbalance, and hemodynamic instability requiring inotrope/vasopressor were also recorded. Hematoma in the postoperative computed tomographic scan, need for reexploration for hematoma evacuation, need for tracheostomy, the number of days of mechanical ventilation, and days of ICU and hospital stay were also noted. Prolonged mechanical ventilation was defined as duration of mechanical ventilation \>48 hours. Similarly, prolonged ICU stay was taken as ICU stay \>2 days and prolonged hospital stay was considered as hospital stay \>7 days. Patient condition at the time of discharge was noted to assign Glasgow Outcome Scale (GOS) grade to assess neurological outcome. GOS grade IV and V were considered "good outcome," whereas GOS Grade I, II, and III were included in "poor outcome."

All the patients were then categorized into four groups on the basis of their estimated intraoperative blood loss as follows:

-   Group A: \<20% blood volume loss

-   Group B: 20 to 50% blood volume loss

-   Group C: \>50 to 100% blood volume loss

-   Group D: blood loss exceeding estimated total blood volume

Occurrence of various perioperative complications was then correlated with the patient groups to identify if there was any association with the amount of intraoperative blood loss.

The primary objective of this study was to study the effects of intraoperative blood loss on perioperative complications and neurological outcome in adult patients undergoing elective brain tumor surgery. The secondary objectives were to identify various risk factors predicting intraoperative blood loss in these patients.

Statistical Analysis
--------------------

The statistical analysis was performed using STATA 12.1 (College Stations, Texas, United States). Data are presented as number (%)/mean ± standard deviation/median (range) as appropriate. For univariate analysis, we used the chi-squared test and the Fisher's exact test (when one or more expected frequencies were \<5) for categorical variables and the Student's *t* -test for continuous variables. Univariate analysis followed by multiple logistic regression analysis was done to identify risk factors and independent predictors for the occurrence of blood loss \>20%. The results are reported as odds ratio (OR) and 95% confidence interval (CI). *p* -Value \< 0.05 was considered statistically significant.

Results
=======

During the study period, 456 patients who underwent elective craniotomy for brain tumor excision qualified for analysis as per the inclusion criteria, and their data were analyzed. After categorization into four groups based on the intraoperative estimated blood volume loss, there were 250 (54.8%) patients in Group A, 154 (33.7%) patients in Group B, 41 (8.9%) patients in Group C, and 11 (2.4%) patients in Group D.

Mean age of our study patients was 37.4 ± 11.5 years. Most of the patients were in the third and fourth decades of life ( [Fig. 1](#FI1900049-1){ref-type="fig"} ). There was almost equal distribution of men and women (246 men \[53.9%\] vs. 210 women \[46.1%\]) ( [Table 1](#TB_1){ref-type="table"} ). The majority of the patients belonged to ASA physical status I (76%) ( [Table 1](#TB_1){ref-type="table"} ). Hypertension (10.9%) was the most common comorbidity followed by diabetes mellitus and hypothyroidism; multiple comorbidities were seen in 14 patients.

![Age-wise distribution of patients in the study groups.](10-1055-s-0039-3399487_0046_01){#FI1900049-1}

###### Demographic characteristics of patients in the study groups

  Variable                    Group A ( *n* = 250)   Group B ( *n* = 154)   Group C ( *n* = 41)   Group D ( *n* = 11)   Total ( *n* = 456)
  --------------------------- ---------------------- ---------------------- --------------------- --------------------- --------------------
  Age (M ± SD), y             37.5 ± 11.6            37.8 ± 11.4            36.4 ± 12.1           34.2 ± 8.1            37.4 ± 11.5
  Male-to-female ratio        156:94                 67:87                  21:20                 2:9                   246:210
  Weight, kg                  62.5 ± 12.8            57.7 ± 11.8            51.7 ± 9.9            47.7 ± 11.5           59.6 ± 12.8
  Comorbidities                                                                                                         
   None                        184 (73.6)             121 (78.57)            32 (78.05)            11 (100)              348 (76.32)
   HTN                        34 (13.6)              10 (6.49)              2 (4.88)              0                     46 (10.09)
   DM                         8 (3.2)                6 (3.9)                2 (4.88)              0                     16 (3.51)
   Hypothyroidism             6 (2.4)                1 (0.65)               2 (4.88)              0                     9 (1.97)
   Cardiac disease            0                      1 (0.65)               0                     0                     1 (0.22)
   Psychiatric disease        3 (1.2)                0                      0                     0                     3 (0.66)
   Others                     8 (3.2)                10 (6.49)              1 (2.44)              0                     19 (4.17)
   Multiple                   7 (2.8)                5 (3.25)               2 (4.88)              0                     14 (3.07)
  ASA physical status grade                                                                                             
   1                          184 (73.6)             120 (77.92)            32 (78.05)            11 (100)              347 (76.1)
   2                          64 (25.6)              32 (20.78)             9 (21.95)             0                     105 (23.03)
   3                          2 (0.8)                2(1.3)                 0                     0                     4 (0.88)

Most patients underwent surgery for excision of primary tumors (98.5%). The tumors were commonly supratentorial (46.9%) in location ( [Table 2](#TB_2){ref-type="table"} ). Histopathologically, about one-third of the patients had glioma (31.5%), followed by meningioma (27.6%) and schwannoma (16%). Eighty-four patients (18.4%) underwent redo surgeries. About 30% patients had large (\>5 cm size) and highly vascular tumors. A little more than three-fourths of our patients had mass effect preoperatively, while only 11.8% and 19.3% patients, respectively, had midline shift \>5 mm and hydrocephalus before surgery.

###### Preoperative characteristics of intracranial tumors in the study groups

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                  Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)
  ------------------------- ------------------------------- ------------------------------- ------------------------------ ------------------------------ -----------------------------
  Tumor location                                                                                                                                          

   Supratentorial           116 (46.4)                      72 (46.75)                      22 (53.66)                     4 (36.36)                      214 (46.93)

   Posterior fossa          28 (11.2)                       15 (9.74)                       3 (7.32)                       3 (27.27)                      49 (10.75)

   Cerebellopontine angle   35 (14)                         21 (13.64)                      6 (14.63)                      3 (27.27)                      65 (14.25)

   Skull base               56 (22.4)                       38 (24.68)                      8 (19.51)                      1 (9.09)                       103 (22.59)

   Intraventricular         15 (6)                          8 (5.19)                        2 (4.88)                       0                              25 (5.48)

  Tumor pathology                                                                                                                                         

   Low-grade glioma         69 (27.6)                       27 (17.53)                      4 (9.76)                       0                              100 (21.93)

   High-grade glioma        19 (7.6)                        17\                             7 (17.07)                      1 (9.09)                       44 (9.65)
                                                            (11.04)                                                                                       

   Meningioma               50 (20)                         54 (35.06)                      18 (43.9)                      4 (36.36)                      126 (27.63)

   Hemangioblastoma         8 (3.2)                         5 (3.25)                        3 (7.32)                       1 (9.09)                       17 (3.73)

   Schwannoma               36 (14.4)                       27 (17.53)                      6 (14.63)                      4 (36.36)                      73 (16.01)

   Pituitary adenoma        8 (3.2)                         5 (3.25)                        0                              0                              13 (2.85)

   Craniopharyngioma        9 (3.6)                         2 (1.3)                         0                              0                              11 (2.41)

   Epidermoid               22 (8.8)                        2 (1.3)                         0                              0                              24 (5.26)

   Medulloblastoma          5 (2)                           2 (1.3)                         1 (2.44)                       0                              8 (1.75)

   Others                   24 (9.6)                        13 (8.44)                       2 (4.88)                       1 (9.09)                       40 (8.77)

  Tumor size, cm                                                                                                                                          

   \<5                      200 (80)                        96 (62.3)                       23 (56.1)                      1 (9.1)                        320 (70.2)

   \>5                      50 (20)                         58 (37.7)                       18 (43.9)                      10 (90.9)                      136 (29.8)

  Other characteristics                                                                                                                                   

   Metastatic tumors        5 (2)                           1 (0.7)                         1 (2.4)                        0                              7(1.5)

   Redo surgeries           45 (18)                         28 (18.2)                       11 (26.8)                      0                              84 (18.4)

   Mass effect              178 (71.2)                      125 (81.2)                      37 (90.2)                      10 (90.9)                      350 (76.8)

   Midline shift            21 (8.4)                        23 (14.9)                       8 (19.5)                       2 (18.2)                       54 (11.8)

   Hydrocephalus            44 (17.6)                       30 (19.5)                       11 (26.8)                      3 (27.3)                       88 (19.3)

   Highly vascular tumors   42 (16.8)                       57 (37)                         23 (56.1)                      6 (54.5)                       128 (28.1)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Nearly, all patients (98.5%) underwent craniotomy under general anesthesia. There were only a few (1.5%) patients who underwent craniotomy under monitored anesthesia care for excision of tumor involving eloquent areas ( [Table 3](#TB_3){ref-type="table"} ). Most patients underwent simple craniotomy (58.5%) in the supine position (67.1%). The mean durations of surgery and anesthesia were 331.3 ± 118.2 minutes (65--800) and 436.3 ± 126.1 minutes (95--870), respectively ( [Table 5](#TB_5){ref-type="table"} ).

###### Various intraoperative variables in the study groups

  Variable                      Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)   *p* -Value
  ----------------------------- ------------------------------- ------------------------------- ------------------------------ ------------------------------ ----------------------------- ------------
  Anesthetic technique                                                                                                                                                                      
   Inhalational                 229 (91.6)                      148 (96.1)                      37 (90.24)                     11 (100)                       425 (93.2)                    0.301
   Total IV                     2 (0.8)                         0                               0                              0                              2 (0.44)                      
   IV plus inhalational         12 (4.8)                        6 (3.9)                         4 (9.76)                       0                              22 (4.82)                     
   MAC                          7(2.8)                          0                               0                              0                              7 (1.54)                      
  Surgical position                                                                                                                                                                         
   Supine                       173 (69.2)                      102 (66.23)                     27 (65.85)                     4 (36.36)                      306 (67.11)                   0.042
   Lateral                      36 (14.4)                       27 (17.53)                      4 (9.76)                       6 (54.55)                      73 (16.01)                    
   Prone                        30 (12)                         17 (11.04)                      10 (24.39)                     1 (9.09)                       58 (12.72)                    
   Sitting                      11 (4.4)                        8 (5.19)                        0                              0                              19 (4.17)                     
  Surgical approach                                                                                                                                                                         
  Simple craniotomy             158 (63.2)                      79 (51.3)                       26 (63.41)                     4 (36.36)                      267 (58.55)                   0.017
   Extended craniotomy          25 (10)                         31 (20.13)                      8 (19.51)                      3 (27.27)                      67 (14.69)                    
   Posterior fossa craniotomy   67 (26.8)                       44 (28.57)                      7 (17.07)                      4 (36.36)                      122 (26.75)                   

The average blood volume loss was 11 ± 5.3% in Group A, 29.8% ± 7.9% in Group B, 68.3 ± 13.5% in Group C, and 129.1 ± 23.9% in Group D. The intergroup comparison showed that the blood loss between the various groups was significantly different ( *p* \< 0.001).

Amounts of crystalloids/colloids administered and urine output were higher through Groups A to D ( [Table 4](#TB_4){ref-type="table"} ); amounts of packed red blood cells (PRBCs), fresh-frozen plasma (FFP), and platelet concentrate (PC) transfused ( *p* \< 0.001) also followed a similar trend. Durations of surgery and anesthesia also increased through Groups A to D ( [Table 5](#TB_5){ref-type="table"} ).

###### Details of blood loss and blood/component transfusion in the study groups

  Variable                            Group A ( *n* = 250)    Group B ( *n* = 154)     Group C ( *n* = 41)     Group D ( *n* = 11)      Total ( *n* = 456)
  ----------------------------------- ----------------------- ------------------------ ----------------------- ------------------------ ------------------------
  Blood loss, mL                      447 ± 226               1,099 ± 360              2,295 ± 634             3,854 ± 1,179            915 ± 806
  Percentage estimated blood volume   11 ± 5.3                29.8 ± 7.9               68.3 ± 13.5             129.1 ± 23.9             25.3 ± 24.7
  RBC transfusion                     32 (12.8)               111 (72.08)              38 (92.68)              11 (100)                 192 (42.11)
  RBC (units)                         1.6 ± 0.7 ( *n* = 32)   2.1 ± 0.9 ( *n* = 111)   4 ± 1.5 ( *n* = 38)     6.2 ± 2.3 ( *n* = 11)    2.6 ± 1.6 ( *n* = 192)
  Cell salvage                        4(1.6)                  18 (11.69)               15 (36.59)              3 (27.27)                40 (8.77)
  Autologous, mL                      377 ± 220 ( *n* = 4)    439 ± 291 ( *n* = 18)    788 ± 492 ( *n* = 15)   1,123 ± 576 ( *n* = 3)   615 ± 443 ( *n* = 40)
  FFP transfusion                     3 (1.2)                 26 (16.88)               26 (63.41)              11 (100)                 66 (14.47)
  FFP (units)                         4.7 ± 1.5 ( *n* = 3)    3.3 ± 1.2 ( *n* = 26)    3.9 ± 0.9 ( *n* = 26)   4.5 ± 2.3 ( *n* = 11)    3.8 ± 2.3 ( *n* = 66)
  PC/PRP transfusion                  3 (1.2)                 16 (10.39)               20 (48.78)              10 (90.91)               49 (10.75)
  PRP (units)                         2.3 ± 1.5 ( *n* = 3)    2.7 ± 1.1 ( *n* = 16)    3.3 ± 1.1 ( *n* = 20)   4.4 ± 1.3 ( *n* = 10)    3.3 ± 1.3 ( *n* = 49)

###### Various intraoperative parameters in the study group

  Variable                      Group A ( *n* = 250)         Group B ( *n* = 154)         Group C ( *n* = 41)           Group D ( *n* = 11)         Total ( *n* = 456)         *p* -Value
  ----------------------------- ---------------------------- ---------------------------- ----------------------------- --------------------------- -------------------------- ------------
  Duration of surgery, min      282.6 ± 91.6                 374.9 ± 110.7                429.7 ± 133.8                 461.8 ± 144.1               331.3 ± 118.2              
  Duration of anesthesia, min   384.7 ± 103.1                483.7 ± 112.8                532.9 ± 137.2                 583.2 ± 162                 436.3 ± 126.1              
  Crystalloids, mL              3,498.4 ± 969.9              4,310.1 ± 1,163.9            5,195.1 ± 1,122.9             7,090.9 ± 3,088.8           4,011.7 ± 1,349.5          
  Colloids, mL                  647.4 ± 255.8 ( *n* = 171)   856.9 ± 359.5 ( *n* = 151)   1,219.5 ± 388.1 ( *n* = 41)   1,400 ± 614.6 ( *n* = 10)   815.3 ± 385 ( *n* = 373)   
  Urine output, mL              1,571.2 ± 798.1              1,844.9 ± 901.5              2,270.7 ± 1,205.1             3,136.4 ± 1,434.9           1,764.3 ± 941.3            
  Reversal                      191 (76.4)                   62 (40.26)                   5 (12.2)                      0                           258 (56.58)                \<0.001
  Extubation                    184 (73.6)                   57 (37.01)                   5 (12.2)                      0                           246 (53.95)                \<0.001
  Ventilation                   67 (26.8)                    97 (62.99)                   36 (87.8)                     11 (100)                    211 (46.27)                \<0.001

The occurrence of hemodynamic instability requiring the use of vasopressors/inotropes and other intraoperative complications such as hypothermia, acidosis, and dyselectrolytemia were significantly more among patients in the groups that had greater blood loss ( [Table 6](#TB_6){ref-type="table"} ).

###### Intraoperative complications

  Variable                   Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)   *p* -Value
  -------------------------- ------------------------------- ------------------------------- ------------------------------ ------------------------------ ----------------------------- ------------
  Hemodynamic instability    1 (0.4)                         2 (1.3)                         8 (19.5)                       6 (54.5)                       17 (3.7)                      \<0.001
  Inotrope/vasopressor use   1 (0.4)                         1 (0.7)                         0                              6 (54.5)                       8 (1.7)                       \<0.001
  Hypothermia                0                               0                               12 (29.3)                      9(81.8)                        21 (4.6)                      \<0.001
  Dyselectrolytemia          0                               0                               0                              1 (9.1)                        1 (0.2)                       0.024
  Acidosis                   0                               0                               2 (4.9)                        0                              2 (0.4)                       0.013
  Difficult hemostasis       1 (0.4)                         0                               1 (2.4)                        0                              2 (0.4)                       0.215

Almost three-fourth of the patients were extubated at the end of surgery in Group A, and the number progressively declined through Group A to Group D. A reverse trend was seen for continuation of mechanical ventilation in the postoperative period among the study groups ( [Table 5](#TB_5){ref-type="table"} ). In almost half of the patients who were electively ventilated at the end of surgery, the reason was either prolonged surgery or surgical concern regarding hemostasis or raised intracranial pressure ( [Table 7](#TB_7){ref-type="table"} ). However, in Group C and Group D, the most common reason for postoperative ventilation was excessive bleeding.

###### Various reasons for elective ventilation in the study patients

  Reason for ventilation       Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)
  ---------------------------- ------------------------------- ------------------------------- ------------------------------ ------------------------------ -----------------------------
  Preoperative LCN palsy       5 (2)                           11 (7.14)                       1 (2.44)                       0                              17 (3.73)
  Brainstem handling           16 (6.4)                        6 (3.9)                         0                              2 (18.18)                      24 (5.26)
  Bleeding                     0                               2 (1.3)                         19 (46.34)                     9(81.82)                       30 (6.58)
  Intraoperative brain bulge   3 (1.2)                         2 (1.3)                         0                              0                              5 (1.1)
  Residual tumor               3 (1.2)                         13 (8.44)                       0                              0                              16 (3.51)
  Prolonged surgery            9 (3.6)                         29 (18.83)                      1 1 (26.83)                    0                              49 (10.75)
  Not obeying commands         8 (3.2)                         5 (3.25)                        0                              0                              13 (2.85)
  Surgical factors             23 (9.2)                        29 (18.83)                      5 (12.2)                       0                              57 (12.5)

During the postoperative period, fever, thrombocytopenia, coagulopathy, pulmonary infections, prolonged ICU stay (\>2 days), and requirement of tracheostomy occurred with significantly higher frequency in patients of Group A through D ( [Table 8](#TB_8){ref-type="table"} ). Development of dyselectrolytemia, hematoma, and requirement of surgical reexploration, blood/component transfusion, and prolonged mechanical ventilation were significantly higher in patients with greater intraoperative blood loss. In patients with postoperative hematoma, operative cavity was the most frequent location ( [Table 9](#TB_9){ref-type="table"} ). The overall median duration of mechanical ventilation ( [Table 10](#TB_10){ref-type="table"} ) was 17 hours (2--624 hours). The median duration of ICU stay was 1.5 days (2--864 hours), and the median hospital stay was 8 days (4--112 days). Chances of poor neurological outcome were significantly higher in patients with greater intraoperative blood loss ( *p* = 0.01).

###### Postoperative complications in the study patients

  Variable                                              Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)   *p* -Value
  ----------------------------------------------------- ------------------------------- ------------------------------- ------------------------------ ------------------------------ ----------------------------- ------------
  Anemia (Hb \< 8 g %)                                  5 (2)                           5 (3.3)                         4(9.8)                         0                              14 (3.1)                      0.091
  Thrombocytopenia (platelet count \<100,000/mm ^3^ )   5 (2)                           15 (9.7)                        13 (31.7)                      6 (54.5)                       39 (8.5)                      \<0.001
  Leukocytosis (TLC \>1 1,000/mm ^3^ )                  149 (59.6)                      98 (63.6)                       23 (56.1)                      7 (63.6)                       277 (60.7)                    0.781
  Fever                                                 58 (23.2)                       66 (42.9)                       21 (51.2)                      10 (90.9)                      155 (33.9)                    \<0.001
  Dyselectrolytemia                                     4(1.6)                          10 (6.5)                        5 (12.2)                       1 (9.1)                        20 (4.4)                      0.003
  Deranged renal function tests                         1 (0.4)                         1 (0.6)                         0                              0                              2 (0.4)                       1.000
  Deranged liver function tests                         0                               0                               1 (2.4)                        0                              1 (0.2)                       0.114
  Coagulopathy                                          2 (0.8)                         3 (1.9)                         6 (14.6)                       2 (18.2)                       13 (2.8)                      \<0.001
  Hemodynamic instability                               3 (1.2)                         1 (0.7)                         1 (2.4)                        0                              5 (1.1)                       0.544
  Inotrope/vasopressor use                              3 (1.2)                         1 (0.7)                         1 (2.4)                        0                              5 (1.1)                       0.544
  Transfusions                                          37 (14.8)                       56 (36.4)                       30 (73.2)                      7 (63.6)                       130 (28.5)                    \<0.001
  Multiorgan dysfunction                                2 (0.8)                         4(2.6)                          1 (2.4)                        0                              7 (1.5)                       0.378
  Pulmonary infection                                   2 (0.8)                         9 (5.8)                         2 (4.9)                        1 (9.1)                        14 (3.1)                      0.006
  Sepsis                                                0                               3 (1.95)                        0                              0                              3 (0.66)                      0.161
  Urinary tract infection                               1 (0.4)                         1 (0.65)                        0                              0                              2 (0.44)                      1.000
  Bloodstream infection                                 0                               1 (0.65)                        1 (2.44)                       0                              2 (0.44)                      0.116
  Wound infection                                       0                               2 (1.3)                         0                              0                              2 (0.44)                      0.329
  Reexploration for hematoma                            6 (2.4)                         4(2.6)                          5 (12.2)                       1 (9.09)                       16 (3.51)                     0.018
  Hematoma                                              29 (11.6)                       28 (18.18)                      12 (29.27)                     3 (27.27)                      72 (15.79)                    0.011
  Tracheostomy                                          5 (2)                           14 (9.09)                       4 (9.76)                       3 (27.27)                      26 (5.7)                      \<0.001
  Prolonged ventilation                                 13 (5.2)                        16 (10.4)                       9(21.9)                        2 (18.2)                       40 (8.7)                      \<0.001
  Prolonged ICU stay                                    13 (5.2)                        23 (14.9)                       8 (19.5)                       4 (36.4)                       48 (10.5)                     \<0.001
  Prolonged hospital stay                               112 (44.8)                      95 (61.7)                       32 (78)                        9(81.8)                        248 (54.4)                    0.054
  Poor neurological outcome                             15 (6)                          17 (11)                         8 (19.5)                       2 (18.2)                       42 (9.2)                      0.013

###### Types of postoperative hematoma in the study patients

  Type of hematoma   Group A ( *n* = 250), *n* (%)   Group B ( *n* = 154), *n* (%)   Group C ( *n* = 41), *n* (%)   Group D ( *n* = 11), *n* (%)   Total ( *n* = 456), *n* (%)   *p* -Value
  ------------------ ------------------------------- ------------------------------- ------------------------------ ------------------------------ ----------------------------- ------------
  Extradural         6 (2.4)                         4 (2.6)                         2 (4.88)                       1 (9.09)                       13 (2.85)                     0.106
  Subdural           0                               0                               1 (2.44)                       0                              1 (0.22)                      
  Intracerebral      1 (0.4)                         2 (1.3)                         1 (2.44)                       1 (9.09)                       5 (1.1)                       
  Subarachnoid       1 (0.4)                         0                               0                              0                              1 (0.22)                      
  Intraventricular   4(1.6)                          6 (3.9)                         2 (4.88)                       0                              12 (2.63)                     
  Tumor cavity       17 (6.8)                        15 (9.74)                       5 (12.2)                       1 (9.09)                       38 (8.33)                     
  Multiple           2 (0.8)                         1 (0.65)                        0                              0                              3 (0.66)                      

###### Postoperative parameters in the study groups

  Variable            Group A ( *n* = 250)    Group B ( *n* = 154)    Group C ( *n* = 41)   Group D ( *n* = 11)     Total ( *n* = 456)
  ------------------- ----------------------- ----------------------- --------------------- ----------------------- ------------------------
  Duration of MV, d   1.4 ± 2.4 ( *n* = 67)   2.3 ± 4.7 ( *n* = 97)   3 ± 5.4 ( *n* = 36)   1.4 ± 1.7 ( *n* = 11)   2.1 ± 4.2 ( *n* = 211)
  ICU stay, d         2 ± 2.7                 3.7 ± 5.3               4.2 ± 5.1             5.1 ± 3.5               2.9 ± 4.1
  Hospital stay, d    9.4 ± 7                 13.6 ± 15.2             14.9 ± 13.4           15.3 ± 7.1              11.5 ± 11.2

On univariate analysis, several demographics and preoperative and intraoperative variables were identified as risk factors for intraoperative bleeding. These included female gender ( *p* \< 0.001), presence of hypertension ( *p* = 0.008), tumor size \>5 cm ( *p* \< 0.001), tumor pathology like high-grade glioma ( *p* = 0.004) and meningioma ( *p* \< 0.001), presence of preoperative mass effect ( *p* = 0.002), preoperative midline shift \>5 mm ( *p* = 0.014), highly vascular tumors as seen on preoperative imaging ( *p* \< 0.001), extended craniotomy approach ( *p* = 0.002), intraoperative use of colloids \>1,000 mL ( *p* \< 0.001), intraoperative brain bulge ( *p* = 0.03), intraoperative appearance as highly vascular tumor ( *p* \< 0.001), and duration of surgery \>300 minutes ( *p* \< 0.001) ( [Table 11](#TB_11){ref-type="table"} ).

###### Predictors of \>20% blood volume loss on univariate analysis

  Variable                        OR      95% CI          *p* -Value
  ------------------------------- ------- --------------- ------------
  Female gender                   2.14    1.468--3.115    0.0001
  HTN                             0.39    0.198--0.78     0.008
  Tumor size \> 5 cm              2.87    1.892--4.344    \<0.001
  HGG                             2.93    1.409--6.088    0.004
  Meningioma                      3.38    1.944--5.888    \<0.001
  Preoperative mass effect        2.05    1.293--3.237    0.0018
  Preoperative midline shift      2.08    1.162--3.721    0.0123
  Vascular tumor (imaging)        3.8     1.794--8.054    \<0.001
  Extended craniotomy approach    2.44    1.402--4.229    0.002
  Colloids \>1,000 mL             23.33   8.371--65.019   \<0.001
  Intraoperative brain bulge      1.75    1.055--2.918    0.03
  High vascularity (appearance)   13.34   6.282--28.315   \<0.001
  Surgery duration \> 300 min     1.01    1.007--1.012    \<0.001

Subsequently, multivariate logistic regression analysis was performed to find out significant risk factors for intraoperative bleeding ( [Table 12](#TB_12){ref-type="table"} ). Female gender ( *p* = 0.002), presence of hypertension ( *p* = 0.017), tumor size \>5 cm ( *p* = 0.008), preoperative and intraoperative appearance of highly vascular tumors ( *p* = 0.041 and *p* = 0.003, respectively), extended craniotomy approach ( *p* = 0.009), intraoperative use of colloids \> 1,000 mL ( *p* \< 0.001), and duration of surgery \>300 minutes ( *p* \< 0.001) were found to be the most predictive variables for intraoperative blood loss ( [Table 11](#TB_11){ref-type="table"} ). However, tumor pathology such as meningioma (OR: 2.34; CI: 1.5--3.5; *p* = 0.065) and tumor location at skull base (OR: 1.02; CI: 0.6--1.6; *p* = 0.063) also demonstrated weak significance ( [Table 12](#TB_12){ref-type="table"} ).

###### Most predictive variables of intraoperative blood loss on multivariate regression analysis

  Variable                        OR      95% CI         *p* -Value
  ------------------------------- ------- -------------- ------------
  Female gender                   2.44    1.37--4.35     0.002
  HTN                             0.33    0.13--0.82     0.017
  Tumor size \>5 cm               2.3     1.24--4.28     0.008
  Vascular tumor (imaging)        2.31    1.32--4.05     0.003
  Extended craniotomy approach    0.63    0.44--0.89     0.009
  Colloids \>1,000 mL             27.32   6.68--111.68   \<0.001
  High vascularity (appearance)   2.09    1.29--3.37     0.003
  Surgery duration \>300 min      1.01    1--1.01        \<0.001
  Pathology--meningioma           0.51    0.24--1.04     0.065
  Location--skull base            0.53    0.26--1.04     0.065

The majority of patients had good neurological recovery (71.3%). Around 19% patients had moderate disability and 5.9% had severe disability. Only two patients (0.4%) were discharged in persistent vegetative state. The mortality rate in our study population was 2.8% ( [Fig. 2](#FI1900049-2){ref-type="fig"} ).

![Glasgow Outcome Scale (GOS) (1 = death, 2 = persistent vegetative state, 3 = severe disability, 4 = moderate disability, 5 = good recovery).](10-1055-s-0039-3399487_0046_02){#FI1900049-2}

Discussion
==========

In this retrospective study, we found that the patients who had \>20% estimated blood volume loss had greater incidence of complications, and the rate was higher with increasing blood loss. Blood transfusion during neurosurgery was found to strongly correlate with postoperative complications in a large retrospective study by Rolston et al. [@JR_15]

Only 42.1% of patients required blood or blood product transfusion in our study, which was slightly less compared with the audit by Bhatnagar et al, [@JR_16] where they found that 48% of their patients with intracranial tumors required transfusion. In our study, 32 (12.8%) patients who had \<20% estimated blood volume loss also received blood transfusion; the reason of transfusion was not mentioned in all anesthesia records but might be due to low baseline hemoglobin, presence of cardiorespiratory comorbidity, rapidity of blood loss, or alarming clinical signs.

Intraoperative complications such as hemodynamic instability requiring inotrope/vasopressor support, hypothermia, and need for elective ventilation postsurgery were more frequent in patients who sustained \>50% estimated blood volume loss. Patients who had \>20% estimated blood volume loss required infusion of more crystalloids and colloids intraoperatively. Colloid infusion more than 1 L was found more commonly in Groups C and D. Similarly, the requirement for blood components such as FFP and PC were also higher in these patients. Piastra et al found that infants who had blood loss exceeding their estimated total blood volume during excision of brain tumor required significantly more intraoperative cardiovascular support. [@JR_13] In addition, they also had significantly higher ICU length of stay and postoperative mechanical ventilation requirement.

In our study, anemia in the postoperative period was slightly more in patients who had \>20% estimated blood volume loss (4.4 vs. 2%). However, this difference was not statistically significant. This probably shows adequacy of transfusion efforts during the intraoperative period. Thrombocytopenia was more common in patients who had \>20% estimated blood volume loss, almost varying linearly with the amount of blood lost. This may be due to the dilutional effect due to infusion of IV fluids, PRBCs, and FFP (poor in platelets).

Postoperatively, fever was more common in patients who had more blood loss, which could be either reactionary to blood transfusion or an early indicator of onset of infection, both of which were more common in patients who had more severe intraoperative bleeding.

Postoperative infections were also positively associated with blood loss and transfusion with most of the infections (pulmonary, bloodstream, wound/surgical site, sepsis, etc.) more frequent in patients who had major blood loss and blood transfusion. Huber-Wagner et al [@JR_17] and Working Group on Polytrauma of the German Trauma Society prospectively studied massive blood transfusion and outcome in 1,062 polytrauma patients and found that \~15% of polytrauma patients who received massive blood transfusion showed risk of organ failure, sepsis, and death correlating with increasing transfusion amount. In our study, risk of postoperative pulmonary infection strongly correlated with intraoperative blood loss and blood/compo-nent transfusion (OR: 24; CI: 1.76--327.3; *p* = 0.017).

The increased incidence of perioperative complications in patients who had \>20% estimated blood volume loss resulted in increased morbidity reflected by prolonged duration of mechanical ventilation, ICU stay, and hospital stay in these patients. Bochicchio et al [@JR_18] found that in trauma patients admitted to ICU, blood product transfusion was associated with a significantly greater infection rate, hospital and ICU stay, ventilator days, and mortality with a dose-dependent correlation.

On regression analysis, several factors were found to positively correlate as risks for intraoperative bleeding. Although all other factors are convincing for their presence, observation of female gender as a significant predictor of intraoperative blood loss is surprising. We did not find any study with similar finding in the literature; therefore, it needs to be further confirmed in larger studies.

Massive intraoperative blood loss has been found to increase the risk of perioperative death by up to eightfold in some studies. [@JR_1] In our study, we found certain predictors of blood loss, of which female gender, tumor size \>5 cm, high vascularity of tumor assessed on the basis of preoperative imaging as well as intraoperative appearance, colloid transfusion \>1 L, and surgery duration \>300 minutes were most notable.

There are certain limitations of this study, including those inherent to all retrospective study designs. Second, all our patients were adults. Third, we included only patients undergoing elective neurosurgery.

Conclusions
===========

Intracranial tumor excision can be associated with major blood loss and require transfusion of large volumes of blood and blood products. This study has identified various factors for intraoperative blood loss during brain tumor surgery. By knowing these predictors, the anesthesiologist can anticipate major blood loss and be prepared to avoid intraoperative hemodynamic instabilities, hypothermia, and acidosis, and make judicious use of blood and blood products, which may go a long way in improving patient outcome.
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